Electromed reported fourth-quarter earnings per share of $0.39, topping the $0.31 estimate by $0.08, while revenue totaled $19.41 million against a $19.5 million consensus. The medical device maker’s EPS beat followed a series of upward revisions over the prior 90 days, per InvestingPro data.
The revenue shortfall marked a contrast to the stronger-than-expected profitability. Shares of Electromed closed at $39.34, up 4.29% over the last three months and 90.42% over the past year. The company’s Financial Health score was rated as "great performance" by InvestingPro, reflecting its recent operational performance.
Electromed’s results were released on August 25, 2026, at 16:32 ET.
